Senior Product Manager, Clinical Markets

NanoString Technologies
Job Location
San Mateo, CA 94403


Job Description

The Senior Product Manager, Clinical Markets will drive development and implementation of strategies to increase NanoString's global installed base within pathology laboratories and drive reagent use within these laboratories.  S/he will manage the nCounter Elements product line globally as well as a growing line of pre-defined panels available for diagnostic use outside the United States. S/he will also be responsible for product lifecycle management of the nCounter DX FLEX Analysis System. This is a global role requiring the ability to define and deploy varying tactics depending on the local market needs and regulations in various countries.  The role requires a high degree of technical expertise balanced by sound business acumen. The ability to synthesize diverse types of information and distill knowledge down to key findings and consequent actions is essential in this role. 

***This position can be based in our Seattle HQ or our San Mateo, CA office


  • Build the Business:  Engage with global sales team to drive business towards revenue targets and key business objectives
  • KOL Management:  Develop a strong Key Opinion Leader network with Medical and Scientific Affairs teams
  • Product Conceptualization:  Responsible for defining compelling product concepts, creating product positioning and value propositions, writing product requirements, proposing pricing strategies, and generating financial models.
  • Product Development and Commercialization:  Support product development and enhancement initiatives by providing inputs to development teams, developing product documentation, managing beta and early access programs, etc.
  • Product Sustaining:  Provide timely support to regional field teams and distributors. 
  • Product Lifecycle Management:  Identify opportunities to enhance the product or customer experience and develop proposals for their implementation.  Execute product obsolescence plans.
  • Market Research and Analysis:  Perform focused research projects including requirements gathering, competitive analysis, market segmentation, pricing/margin analysis, etc.
  • Marketing Communications:  Develop and implement sales support tools and training programs required by customer-facing staff.  Work with Marketing Communications and Regional Marketing Teams to define, deploy, and measure success of campaigns and collateral.


  • At least five (5) years' experience in product management or other commercial role in Molecular Diagnostics industry.
  • Thorough understanding of current market needs for molecular diagnostic both within and outside of the United States.
  • International Work Experience
  • Business or Scientific Degree
  • Highly effective presentation and public speaking skills.
  • Ability to work effectively in cross functional environment.
  • Demonstrates a bias for action and results. Takes ownership of important issues. Demonstrates persistence in the face of obstacles.
  • Collaborates well with others. Builds effective business relationships.
  • Is curious and inquisitive. Achieves innovative solutions. Approaches problems from a customer perspective. Develops solutions with sustainable and scalable results.
  • Self-motivated, highly organized, and meticulous in details.
  • Exceptional analytical skills and proficiency with MS Excel
  • Willingness to travel up to 25% of the time.
  • Must be able to work independently, manage multiple projects, communicate proactively, and prioritize daily tasks. 
About Our Organization

NanoString Technologies is a publicly held provider of life science tools for translational research and molecular diagnostics. The company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications.

NanoString's products are based on a novel digital molecular barcoding technology invented at the Institute for Systems Biology (ISB) in Seattle under direction of Dr. Leroy Hood. The company was founded in 2003 with an exclusive license to develop and market the technology. In 2008, NanoString launched its first commercial instrument system and began international sales operations with its first multiplexed assays for gene expression analysis. In 2010, the company launched new applications for the system to support microRNA analysis and copy number variation detection, and in 2013 launched Prosigna, its first in vitro diagnostic product for prognosis of early stage breast cancer.

An analysis appearing in PeerJ finds that social media mentions of a paper may lead to increased citations.

NIH's Michael Lauer looks at the number of grants, their amount, and funding success rates at the agency for last year.

At Nature, Johns Hopkins' Gundula Bosch describes her graduate program that aims to get doctoral students thinking about the big picture.

Patricia Fara writes about childcare funding, and women in science and science history at NPR.